RAYMOND P SMITH
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology QUINCY, IL NPI 1477526259
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology IL Acerta Pharma LLC All categories
General Payments — all program years on this page
$10,521.01
- Category: General Payments
- Program years: PY2018–2024
- Record count: 597
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,524.11 across 76 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,524.11 | 76 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $156.31 | 8 |
| PFIZER INC. | $135.87 | 9 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $119.78 | 5 |
| Incyte Corporation | $104.89 | 5 |
| Astellas Pharma US Inc | $96.98 | 4 |
| Daiichi Sankyo Inc. | $95.03 | 4 |
| Celgene Corporation | $92.79 | 5 |
| Merck Sharp & Dohme Corporation | $80.48 | 4 |
| Regeneron Healthcare Solutions, Inc. | $80.30 | 3 |
| Gilead Sciences, Inc. | $79.30 | 5 |
| Genentech USA, Inc. | $76.99 | 4 |
| Janssen Biotech, Inc. | $56.77 | 3 |
| E.R. Squibb & Sons, L.L.C. | $48.36 | 2 |
| AVEO Pharmaceuticals, Inc. | $45.01 | 2 |
| ABBVIE INC. | $43.59 | 2 |
| SOBI, INC | $40.80 | 2 |
| BeiGene USA, Inc. | $28.47 | 1 |
| ADC Therapeutics America, Inc. | $26.85 | 1 |
| Karyopharm Therapeutics Inc. | $18.97 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.83 | 1 |
| Myriad Genetic Laboratories, Inc. | $17.44 | 1 |
| Lilly USA, LLC | $16.09 | 1 |
| Pharmacosmos Therapeutics Inc. | $15.74 | 1 |
| EMD Serono, Inc. | $15.13 | 1 |
| Spectrum Pharmaceuticals Inc. | $14.34 | 1 |
By program year
Records — PY2024 (76)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.